Index of reports
> Cases with Neoplasm Malignant (29)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydroxyurea where reactions include neoplasm malignant. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Hydroxyurea side effects in
Reported by a consumer/non-health professional from United States on 2012-06-19
Patient:
Reactions: Myelofibrosis, Pharyngeal Disorder, Neoplasm Malignant, Mouth Ulceration, Thrombocytosis, Blood Disorder, Oropharyngeal Blistering, Skin Reaction
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Anagrelide HCL
Dosage: 0.5 mg, qd
Indication: Essential Thrombocythaemia
Start date: 2009-12-01
End date: 2010-01-26
Hydroxyurea
Dosage: 750 mg, qd
Start date: 1994-04-22
End date: 2008-06-12
Hydroxyurea
Dosage: 714 mg, qd
Indication: Essential Thrombocythaemia
Start date: 2008-06-12
End date: 2010-01-26
Hydroxyurea
Dosage: 857 mg, qd
Start date: 2010-01-26
Clopidogrel
Dosage: 75 mg, qd
Indication: Essential Thrombocythaemia
Start date: 2010-01-23
End date: 2010-06-15
Aspirin
Dosage: 75 mg, qd
Start date: 2007-04-06
End date: 2010-03-23
Aspirin
Dosage: 75 mg, qd
Start date: 2010-05-10
Other drugs received by patient: Allopurinol
Possible Hydroxyurea side effects in 68 year old male
Reported by a consumer/non-health professional from Germany on 2012-04-13
Patient: 68 year old male
Reactions: Neoplasm Malignant, Cardiac Failure, Major Depression, Penis Carcinoma, Spinal Osteoarthritis, Leukocytosis, Haemorrhoidal Haemorrhage
Drug(s) suspected as cause:
Hydroxyurea
Indication: Chronic Myeloid Leukaemia
Start date: 2002-01-01
End date: 2011-01-01
Nilotinib
Start date: 2008-01-01
Thioguanine
Start date: 2009-01-01
End date: 2011-01-01
Imatinib Mesylate
Dosage: also received in 2010
Indication: Chronic Myeloid Leukaemia
Start date: 2004-01-01
Possible Hydroxyurea side effects in 68 year old male
Reported by a physician from Germany on 2012-04-04
Patient: 68 year old male
Reactions: Cardiac Failure, Neoplasm Malignant, Major Depression, Spinal Osteoarthritis, Penis Carcinoma, Leukocytosis, Haemorrhoidal Haemorrhage
Drug(s) suspected as cause:
Thioguanine
Start date: 2009-01-01
End date: 2011-01-01
Hydroxyurea
Indication: Chronic Myeloid Leukaemia
Start date: 2002-01-01
End date: 2011-01-01
Imatinib Mesylate
Dosage: also received in 2010
Indication: Chronic Myeloid Leukaemia
Start date: 2004-01-01
Nilotinib
Start date: 2008-01-01
Possible Hydroxyurea side effects in male
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-04-02
Patient: male
Reactions: Pneumonia, Neoplasm Malignant, Acute Myeloid Leukaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Dasatinib
Dosage: then 80mg/d for 17 months
Indication: Chronic Myeloid Leukaemia
Start date: 2008-11-01
End date: 2010-07-01
Daunorubicin HCL
Indication: Chronic Myeloid Leukaemia
Azacitidine
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: dose reduced to 300mg/d
Indication: Chronic Myeloid Leukaemia
Start date: 2003-01-01
End date: 2007-12-01
Hydroxyurea
Indication: Chronic Myeloid Leukaemia
Nilotinib
Indication: Chronic Myeloid Leukaemia
Start date: 2008-01-01
End date: 2008-07-01
Cytarabine
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 57 year old male
Reported by a physician from Germany on 2012-03-27
Patient: 57 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Respiratory Disorder, Pneumonia, Cholestasis, Transaminases Increased, Pericardial Effusion, Neoplasm Malignant, Pleural Effusion, Thrombocytopenia, Pneumonitis, Leukopenia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Hydroxyurea
Dosage: 5 days
Start date: 2009-09-02
Interferon Alfa
Dosage: 1df= 1.0 million;08dec2009-dec2010
Indication: Chronic Myeloid Leukaemia
Start date: 2009-12-08
End date: 2010-06-01
Sprycel
Dosage: paused since 03jan2011 and discontinued on 18jan2011
Administration route: Oral
Indication: Chronic Myeloid Leukaemia
End date: 2011-01-18
Imatinib Mesylate
Dosage: 15sep2009-dec2010
Indication: Chronic Myeloid Leukaemia
Start date: 2009-09-15
Possible Hydroxyurea side effects in male
Reported by a health professional (non-physician/pharmacist) from Poland on 2012-03-25
Patient: male
Reactions: Pneumonia, Neoplasm Malignant, Acute Myeloid Leukaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: dose reduced to 300mg/d
Indication: Chronic Myeloid Leukaemia
Start date: 2003-01-01
End date: 2007-12-01
Nilotinib
Indication: Chronic Myeloid Leukaemia
Start date: 2008-01-01
End date: 2008-07-01
Daunorubicin HCL
Indication: Chronic Myeloid Leukaemia
Azacitidine
Indication: Chronic Myeloid Leukaemia
Dasatinib
Dosage: then 80mg/d for 17 months
Indication: Chronic Myeloid Leukaemia
Start date: 2008-11-01
End date: 2010-07-01
Hydroxyurea
Indication: Chronic Myeloid Leukaemia
Cytarabine
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 62 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-23
Patient: 62 year old male
Reactions: Neoplasm Malignant, Lung Neoplasm Malignant
Drug(s) suspected as cause:
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Interferon
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 55 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20
Patient: 55 year old male
Reactions: Colon Cancer, Neoplasm Malignant
Drug(s) suspected as cause:
Hydroxyurea
Indication: Chronic Myeloid Leukaemia
Dasatinib
Indication: Chronic Myeloid Leukaemia
Nilotinib
Indication: Chronic Myeloid Leukaemia
Interferon
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 68 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20
Patient: 68 year old female
Reactions: Phaeochromocytoma, Neoplasm Malignant
Drug(s) suspected as cause:
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20
Patient: 43 year old male
Reactions: Neoplasm Malignant, Anal Cancer
Drug(s) suspected as cause:
Imatinib Mesylate
Indication: Chronic Myeloid Leukaemia
Busulfan
Indication: Chronic Myeloid Leukaemia
Interferon
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 53 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20
Patient: 53 year old male
Reactions: Neoplasm Malignant, Carcinoid Tumour of THE Small Bowel
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Interferon
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20
Patient: 65 year old female
Reactions: Myelofibrosis, Neoplasm Malignant
Drug(s) suspected as cause:
Nilotinib
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Indication: Chronic Myeloid Leukaemia
Dasatinib
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20
Patient: 49 year old female
Reactions: Breast Cancer, Neoplasm Malignant
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20
Patient: 69 year old male
Reactions: Neoplasm Malignant, Gastric Cancer
Drug(s) suspected as cause:
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 52 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-20
Patient: 52 year old male
Reactions: Neoplasm Malignant, Prostate Cancer
Drug(s) suspected as cause:
Interferon
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 32 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-19
Patient: 32 year old female
Reactions: Neoplasm Malignant, Cervix Carcinoma Stage 0
Drug(s) suspected as cause:
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-19
Patient: 71 year old male
Reactions: Chronic Lymphocytic Leukaemia, Neoplasm Malignant
Drug(s) suspected as cause:
Interferon
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 63 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-19
Patient: 63 year old male
Reactions: Prostate Cancer, Neoplasm Malignant
Drug(s) suspected as cause:
Interferon
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Cytarabine
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 74 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 74 year old male
Reactions: Malignant Neoplasm of Ampulla of Vater, Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Interferon
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Other drugs received by patient: Cytarabine
Possible Hydroxyurea side effects in 59 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 59 year old male
Reactions: Death, Neoplasm Malignant, Malignant Melanoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Other drugs received by patient: Interferon
Possible Hydroxyurea side effects in 68 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 68 year old male
Reactions: Neoplasm Malignant, Lung Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Interferon
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 73 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 73 year old female
Reactions: Adenocarcinoma Pancreas, Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Imatinib Mesylate
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 72 year old female
Reactions: Uterine Cancer, Death, Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 41 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 41 year old male
Reactions: Colon Cancer, Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Interferon
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Cytarabine
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 62 year old female
Reactions: Neoplasm Malignant, Lung Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 68 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 68 year old male
Reactions: Lung Adenocarcinoma, Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 46 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 46 year old male
Reactions: Lung Adenocarcinoma, Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Interferon
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Dasatinib
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 36 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 36 year old male
Reactions: Seminoma, Neoplasm Malignant, Chronic Myeloid Leukaemia
Adverse event resulted in: death
Drug(s) suspected as cause:
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Interferon
Dosage: unk
Indication: Chronic Myeloid Leukaemia
Busulfan
Indication: Chronic Myeloid Leukaemia
Possible Hydroxyurea side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Czech Republic on 2012-01-18
Patient: 71 year old male
Reactions: Laryngeal Cancer, Neoplasm Malignant
Adverse event resulted in: death
Drug(s) suspected as cause:
Imatinib Mesylate
Dosage: unk ukn, unk
Indication: Chronic Myeloid Leukaemia
Hydroxyurea
Dosage: unk
Indication: Chronic Myeloid Leukaemia
|